Computable Authority for Pharma & Life Sciences AI
Trial eligibility, pharmacovigilance and submission checks follow pre-specified criteria. NOMOS seals those criteria with their source, applies them identically at every site, and records which criterion decided each case.
Seal your rules in Studio →The challenge in pharma & life sciences
Where written policy and what automated systems actually do can come apart.
✕Clinical trial patient eligibility AI applying inclusion/exclusion criteria inconsistently across sites without audit trail
✕Pharmacovigilance AI missing adverse event signals because rule thresholds were tuned informally post-validation
✕Drug interaction prediction models with no machine-readable documentation of the decision logic for regulatory submissions
✕Real-world evidence AI applying data inclusion criteria that diverge from pre-specified statistical analysis plan
AI use cases NOMOS checks in pharma & life sciences
Clinical trial patient matchingDrug discovery lead prioritisationPharmacovigilance signal detectionRegulatory submission evidence generationReal-world evidence analysis
Regulations that apply
Laws and standards that bear on these decisions, each summarised from its official text, with what NOMOS records.
See how NOMOS checks pharma & life sciences AI
Upload a policy. Studio states each rule with the sentence it came from, finds contradictions, and seals the rules a person has confirmed.